Insulin requirement profiles in Japanese hospitalized subjects with type 2 diabetes treated with basal-bolus insulin therapy
- PMID: 25392020
- DOI: 10.1507/endocrj.EJ14-0487
Insulin requirement profiles in Japanese hospitalized subjects with type 2 diabetes treated with basal-bolus insulin therapy
Abstract
To assess the total daily inulin dose (TDD) and contribution of basal insulin to TDD and to identify the predictive factors for insulin requirement profiles in subjects with type 2 diabetes, we retrospectively examined insulin requirement profiles of 275 hospitalized subjects treated with basal-bolus insulin therapy (BBT) (mean age, 60.1 ± 12.9 years; HbA1c, 10.2 ± 4.5%). Target plasma glucose level was set between 80 and 129 mg/dL before breakfast and between 80 and 179 mg/dL at 2-hour after each meal without causing hypoglycemia. We also analyzed the relationship between the insulin requirement profiles (TDD and basal/total daily insulin ratio [B/TD ratio]) and insulin-associated clinical parameters. The mean TDD was 0.463 ± 0.190 unit/kg/day (range, 0.16-1.13 unit/kg/day). The mean B/TD ratio was 0.300 ± 0.099 (range, 0.091-0.667). A positive correlation of TDD with B/TD ratio was revealed by linear regression analysis (r=0.129, p=0.03). Stepwise multiple regression analysis identified post-breakfast glucose levels before titrating insulin as an independent determinant of the insulin requirement profile [Std β (standard regression coefficient) = 0.228, p<0.01 for TDD, Std β = -0.189, p<0.01 for B/TD ratio]. The TDD was <0.6 unit/kg/day and the B/TD ratio was <0.4 in the majority (70.2%) of subjects in the present study. These findings may have relevance in improving glycemic control and decreasing the risk of hypoglycemia and weight gain in subjects with type 2 diabetes treated with BBT.
Similar articles
-
Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial.Diabetes Obes Metab. 2016 May;18(5):500-7. doi: 10.1111/dom.12642. Epub 2016 Mar 22. Diabetes Obes Metab. 2016. PMID: 26854123 Free PMC article. Clinical Trial.
-
Hypoglycemia observed during continuous glucose monitoring in patients with type 2 diabetes mellitus treated by subcutaneous insulin injection.Diabetes Technol Ther. 2013 Jul;15(7):586-90. doi: 10.1089/dia.2013.0034. Epub 2013 Apr 11. Diabetes Technol Ther. 2013. PMID: 23578166
-
Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes.Sci China Life Sci. 2019 Nov;62(11):1506-1513. doi: 10.1007/s11427-018-9530-3. Epub 2019 May 22. Sci China Life Sci. 2019. PMID: 31197759
-
Approaches to rapid acting insulin intensification in patients with type 2 diabetes mellitus not achieving glycemic targets.Ann Med. 2018 Sep;50(6):453-460. doi: 10.1080/07853890.2018.1493216. Epub 2018 Aug 25. Ann Med. 2018. PMID: 30103624 Review.
-
Methods to enhance delivery of prandial insulin and basal-prandial insulin.Diabetes Obes Metab. 2013 Mar;15 Suppl 1:11-7. doi: 10.1111/dom.12067. Diabetes Obes Metab. 2013. PMID: 23448198 Review.
Cited by
-
Novel trends and concepts in the nutritional management of glycemia in type 2 diabetes mellitus-beyond dietary patterns: a narrative review.Hormones (Athens). 2021 Dec;20(4):641-655. doi: 10.1007/s42000-021-00314-1. Epub 2021 Aug 29. Hormones (Athens). 2021. PMID: 34455577 Review.
-
Remission of Insulin-Dependent Diabetes Mellitus in Multiple Endocrine Neoplasia Type 2A After Adrenalectomy.JCEM Case Rep. 2025 Jan 9;3(1):luae240. doi: 10.1210/jcemcr/luae240. eCollection 2025 Jan. JCEM Case Rep. 2025. PMID: 39790937 Free PMC article.
-
Basal insulin ameliorates post-breakfast hyperglycemia via suppression of post-breakfast proinsulin/C-peptide ratio and fasting serum free fatty acid levels in patients with type 2 diabetes.Diabetol Int. 2020 Aug 3;12(2):161-170. doi: 10.1007/s13340-020-00457-3. eCollection 2021 Apr. Diabetol Int. 2020. PMID: 33786271 Free PMC article.
-
Excess weight gain during insulin pump therapy is associated with higher basal insulin doses.J Diabetes Metab Disord. 2016 Oct 18;15:47. doi: 10.1186/s40200-016-0271-5. eCollection 2016. J Diabetes Metab Disord. 2016. PMID: 27777901 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous